Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia.

@article{Molina2010InhaledCU,
  title={Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia.},
  author={Rosa Malo de Molina and Eric M Mortensen and Marcos I Restrepo and Laurel A Copeland and Mary Jo Pugh and Antonio Anzueto},
  journal={The European respiratory journal},
  year={2010},
  volume={36 4},
  pages={751-7}
}
Recent studies suggest that use of inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease (COPD) may be associated with a higher incidence of pneumonia. However, it is unclear whether COPD subjects on ICS who develop pneumonia have worse outcomes. Therefore, our aim was to examine the association of prior outpatient ICS therapy with mortality in hospitalised COPD subjects with pneumonia. We included subjects ≥64 yrs of age, hospitalised with pneumonia in US Veterans Affairs… CONTINUE READING

From This Paper

Topics from this paper.
30 Citations
52 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 52 references

Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations

  • GT Ferguson, A Antonio, F Richard
  • Respir Med
  • 2008

Similar Papers

Loading similar papers…